„”
Dr.
The molecular mechanisms mediating class II PI 3‐kinase function in cell physiology
The FEBS Journal 2021
read onlineDissecting the activation of insulin degrading enzyme by inositol pyrophosphates and their bisphosphonate analogs
Chemical Science 2021
read onlineMolecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases.
Frontiers in Immunology 2018
read onlineProbing the Architecture, Dynamics, and Inhibition of the PI4KIIIα/TTC7/FAM126 Complex
Journal of Molecular Biology 2018
read onlineArchitecture of eukaryotic mRNA 3'-end processing machinery.
Science (New York, N.Y.) 2017
read onlineNovel PIK3CD mutations affecting N-terminal residues of p110δ cause activated PI3Kδ syndrome (APDS) in humans.
The Journal of allergy and clinical immunology 2017
read onlineConformational disruption of PI3Kδ regulation by immunodeficiency mutations in PIK3CD and PIK3R1.
Proceedings of the National Academy of Sciences of the United States of America 2017
read onlineUsing Hydrogen-Deuterium Exchange Mass Spectrometry to Examine Protein-Membrane Interactions.
Methods in enzymology 2016
read onlineDiversity-oriented synthesis yields novel multistage antimalarial inhibitors.
Nature 2016
read onlineDesign and Structural Characterization of Potent and Selective Inhibitors of Phosphatidylinositol 4 Kinase IIIβ.
Journal of medicinal chemistry 2016
read onlineType III phosphatidylinositol 4 kinases: structure, function, regulation, signalling and involvement in disease.
Biochemical Society transactions 2016
read onlineThe Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) is part of the Forschungsverbund Berlin e.V. (FVB), which legally represents seven non-university research institutes - members of the Leibniz Association - in Berlin.
Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP)
Campus Berlin-Buch
Robert-Roessle-Str. 10,
13125 Berlin, Germany